Loading…
Borosil Scientific (BOROSCI)₹110.09−1.47%Glass - Industrial
In the Sep 2026 quarter (consolidated), Borosil Scientific reported sales of ₹115 Cr, up 7.4% from Sep 2025, and net profit of ₹5.28 Cr, up 86.6% year on year. For the year to Mar 2026, sales were ₹463 Cr and net profit ₹34.88 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 99.78 | 116 | 104 | 103 | 102 | 130 | 96.10 | 107 | 121 | 143 | 107 | 115 |
| Expenses | 87.32 | 97.19 | 94.08 | 86.96 | 91.13 | 113 | 90.87 | 98.57 | 104 | 111 | 97.99 | 104 |
| Operating Profit | 12.17 | 18.31 | 9.84 | 15.85 | 10.03 | 16.60 | 4.87 | 8.05 | 17.22 | 32.19 | 8.46 | 10.73 |
| OPM % | 12.3% | 15.8% | 9.5% | 15.4% | 9.9% | 12.8% | 5.1% | 7.6% | 14.2% | 22.5% | 8.0% | 9.4% |
| Other Income | 1.07 | 1.49 | 2.17 | 1.59 | 1.87 | 2.60 | −3.70 | 2.16 | 0.51 | 2.07 | 2.68 | 2.42 |
| Interest | 0.53 | 0.66 | 0.39 | 0.35 | 0.34 | 0.43 | 0.37 | 0.22 | 0.25 | 0.25 | 0.24 | 0.21 |
| Depreciation | 4.51 | 4.46 | 4.58 | 4.64 | 4.59 | 4.71 | 4.89 | 4.82 | 4.80 | 4.77 | 4.90 | 5.23 |
| Profit before tax | 8.20 | 14.68 | 7.04 | 12.45 | 6.96 | 14.07 | −4.10 | 5.15 | 12.67 | 29.26 | 5.99 | 7.70 |
| Tax % | 30.4% | 35.2% | 28.4% | 29.0% | 38.2% | 38.5% | 3.2% | 44.3% | 31.2% | 6.5% | 27.0% | 30.8% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −5.99 | 0.00 | −0.99 | 0.00 | 0.00 | 0.00 |
| Net Profit | 5.67 | 9.43 | 5.01 | 8.77 | 4.26 | 8.59 | −4.19 | 2.83 | 8.67 | 27.16 | 4.33 | 5.28 |
| EPS (Rs) | 0.64 | 1.04 | 0.56 | 0.98 | 0.47 | 0.96 | −0.46 | 0.31 | 0.99 | 3.05 | 0.50 | 0.59 |
| Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|
| Sales | 393 | 435 | 463 | 487 |
| Expenses | 344 | 380 | 399 | 417 |
| Operating Profit | 47.11 | 53.11 | 63.17 | 68.60 |
| OPM % | 12.0% | 12.0% | 14.1% | 14.1% |
| Other Income | 4.01 | 8.02 | 0.00 | 7.68 |
| Interest | 2.99 | 1.99 | 0.99 | 0.95 |
| Depreciation | 16.03 | 18.03 | 19.02 | 19.70 |
| Profit before tax | 32.10 | 40.14 | 43.16 | 55.62 |
| Tax % | 25.9% | 33.9% | 18.9% | — |
| Exceptional items | 0.00 | 0.00 | −5.99 | −0.99 |
| Net Profit | 22.93 | 26.89 | 34.88 | 45.44 |
| EPS (Rs) | 2.64 | 3.00 | 3.88 | 5.13 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | — |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 8.97 | 8.97 | 8.98 |
| Reserves | 368 | 395 | 433 |
| Borrowings | 18.06 | 14.04 | 9.02 |
| Other Liabilities | 94.81 | 85.98 | 89.79 |
| Total Liabilities | 489 | 504 | 541 |
| Fixed Assets | 192 | 187 | 189 |
| CWIP | 1.01 | 1.01 | 9.02 |
| Investments | 0.00 | 105 | 122 |
| Other Assets | 296 | 211 | 221 |
| Inventories | 96.95 | 96.85 | 103 |
| Trade receivables | 61.18 | 71.21 | 76.30 |
| Cash & equivalents | 14.05 | 15.04 | 14.04 |
| Total Assets | 489 | 504 | 541 |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Cash from operating activity | 29.93 | 120 | 42.94 |
| Cash from investing activity | −2.01 | −115 | −37.05 |
| Cash from financing activity | −15.95 | −2.99 | −5.99 |
| Net cash flow | 11.95 | 0.99 | 0.00 |
| Capex | 12.86 | 14.15 | 28.43 |
| Free cash flow | 16.99 | 106 | 16.01 |
| CFO / OP % | 97.0% | 249.0% | 92.0% |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor days | 57 | 59 | 60 |
| Inventory days | 244 | 218 | 226 |
| Days payable | 103 | 80 | 94 |
| Cash conversion cycle | 200 | 199 | 193 |
| Working capital days | 164 | 85 | 83 |
| ROCE % | — | 10.0% | 12.0% |
For the Sep 2026 quarter, Borosil Scientific reported sales of ₹115 Cr, up 7.4% year on year and net profit of ₹5.28 Cr, up 86.6% year on year. The operating margin was 9.4%.
Borosil Scientific's sales for the year to Mar 2026 were ₹463 Cr; over the last twelve months they were ₹487 Cr.
Net profit for the year to Mar 2026 was ₹34.88 Cr, and ₹45.44 Cr over the last twelve months. Earnings per share over the same trailing period were ₹5.13.
Borosil Scientific reported borrowings of ₹9.02 Cr at Mar 2026, against cash and equivalents of ₹14.04 Cr.
Cash from operations was ₹42.94 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹16.01 Cr.